Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing.
We support a large global customer base which includes hospitals to large corporates. Our proprietary technology platform NOVAPREP® is a unique next generation liquid based cytology solution focused on cancer management.
Market capitalization (16-Jun-2017)
Closing share price (16-Jun-2017)